Raspberry seeds extract selectively inhibits the growth of human lung cancer cells in vitro

6Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This study was focused on in vitro cytotoxicity screening of the raspberry seeds methanol extract towards a number of cancer cell lines of human origin. The tested extract at the preferred concentrations (IC50 <30 µg/mL) inhibited only the growth of the lung cancer A-549 cells (IC50 = 14.07 ± 0.96 µg/mL). At the same time, it was practically inactive (IC50 >300 µg/mL) and non-mutagenic towards normal MRC-5 lung cells. Finally, the extract potently scavenged both OH· (IC50 = 20.11 ± 1.77 µg/mL) and O2-· (IC50 = 47.23 ± 3.82 µg/mL), the free radicals of proved relevance for cancer pathophysiology. Though seeds were enriched with phenolic compounds (TPC = 5.21 ± 0.07 mg GAE/g), anthocyanins were present in traces only (TAC = 0.07 ± 0.003 mg cyn-3-glu/g), while flavonoids were not detected at all. This is the first report on anti-lung cancer potential of the seeds of any soft fruit.

Cite

CITATION STYLE

APA

Simonovic, M., Kojic, V., Jakimov, D., Glumac, M., & Pejin, B. (2021). Raspberry seeds extract selectively inhibits the growth of human lung cancer cells in vitro. Natural Product Research, 35(13), 2253–2256. https://doi.org/10.1080/14786419.2019.1666391

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free